<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02853214</url>
  </required_header>
  <id_info>
    <org_study_id>2007-460</org_study_id>
    <nct_id>NCT02853214</nct_id>
  </id_info>
  <brief_title>Familial Dysglobulinemia</brief_title>
  <acronym>PreFamDys</acronym>
  <official_title>Identification of Genetic Factors Predisposing to Dysglobulinemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multiple Myeloma (MM) is a malignant proliferation of monoclonal plasma cells. Myeloma
      accounts for almost 14% of all hematologic cancers and is essentially incurable. Myeloma
      commonly evolves from a precursor disease, Monoclonal gammopathy of undetermined significance
      (MGUS). Despite intensive study, the etiology of MGUS and myeloma are unknown and no
      lifestyle or environmental exposure factors have been identified that are consistently linked
      to increased risk of MM, MGUS or the transition between the two.

      The overall goal is to identify risk genes for dysglobulinemia, and more specifically
      Multiple Myeloma. This will involve the conservation of cells in a bank and genetic
      sequencing on samples obtained from families with at least two cases of dysglobulinemia.
      Material used for sequencing is likely to include fresh peripheral blood cells or
      lymphoblastoid lines established from peripheral blood lymphocytes of patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 6, 2008</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">February 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Data of a bank cells, clinically annotated, from families with at least 2 cases of dysglobulinemia and at least 1 case alive.plasma cell dysplasia</measure>
    <time_frame>up to 48 months</time_frame>
    <description>The investigator collects blood samples from patients with dysglobulinemia and their relatives and with this, the investigators constitutes the bank cells thanks to the establishment of lymphoblastoid cell lines.
The investigator considers as &quot;dysglobulinemia&quot; cases patients with Multiple Myeloma, MGUS, Waldenström's disease and MGUS (monoclonal gammopathy of unknown significance ) as wells as plasmacytomas confirmed histologically or cytologically.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Single Nucleotide Polymorphism array for identification of polymorphisms predictive of dysglobulinemia</measure>
    <time_frame>at day 0</time_frame>
    <description>The biological material, obtained from fresh peripheral blood cells and from Lymphoblastoid cells lines, is used for pangenic sequencing. It allows to better understand the mechanism of genetic variations who could be involve in the myeloma genesis</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Dysglobulinemia</condition>
  <arm_group>
    <arm_group_label>Identification of genetic factors in dysglobulinemia cases</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Genetic analysis of peripheral blood samples</intervention_name>
    <description>M.D investigators report the identified families with all the information: description of the familial area (for example: 2 cases father and son), last medical report for the case with the type of dysglobulinemia, monoclonal component isotype, medical background and contact information for one of the patients or cases with Name/surname/Date of Birth/address and phone. They contact the patient to explain the study and establish the family pedigree. They collect the information on all the family members and send to the patient a mail: an information note on the study, a prescription for the blood sample and the informed consents. They proceed in the same way for the relatives with the additional prescription: EIP. They organize the logistic in the medical lab or hospital chosen by the person. They receive 4 Heparin and 1 serum tubes for each and with this, they obtain a large amount of biological material for the genetic analysis thanks to the establishment of lymphoblastoid cell lines</description>
    <arm_group_label>Identification of genetic factors in dysglobulinemia cases</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  2 cases per family at least

          -  1 case alive at least

          -  biological material available for 1 case at least

          -  Patients give their informed consent

          -  attached to the French Health protection service

        Exclusion Criteria:

          -  Age under 18
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Charles DUMONTET</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Charles DUMONTET, MD</last_name>
    <phone_ext>+33</phone_ext>
    <email>charles.dumontet@chu-lyon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Delphine DEMANGEL</last_name>
    <email>delphine.demangel@univ-lyon1.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU d'ABBEVILLE</name>
      <address>
        <city>Abbeville</city>
        <zip>80100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle Marie Blanche LEDUC, MD</last_name>
    </contact>
    <investigator>
      <last_name>Isabelle Marie Blanche LEDUC, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Groupe Hospitalier Sud Hématologie Clinique</name>
      <address>
        <city>Amiens</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Pierre MAROLLEAU, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jean-Pierre MAROLLEAU, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH d'Avignon</name>
      <address>
        <city>Avignon</city>
        <zip>84902</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Slama BORHANE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Slama BORHANE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Besançon</name>
      <address>
        <city>Besançon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean FONTAN, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jean FONTAN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Blois Service d'Hématologie</name>
      <address>
        <city>Blois</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe RODON, MD</last_name>
    </contact>
    <investigator>
      <last_name>Philippe RODON, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Avicenne Service d'Hématologie</name>
      <address>
        <city>Bobigny</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe CASASSUS, MD</last_name>
    </contact>
    <investigator>
      <last_name>Philippe CASASSUS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service d'Hématologie clinique et Thérapie Cellulaire, CHU de BORDEAUX</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gérald MARIT, MD</last_name>
    </contact>
    <investigator>
      <last_name>Gérald MARIT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Morvan</name>
      <address>
        <city>Brest</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian BERTHOU, MD</last_name>
    </contact>
    <investigator>
      <last_name>Christian BERTHOU, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service d'hématologie Clinique</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret MACRO, MD</last_name>
    </contact>
    <investigator>
      <last_name>Margaret MACRO, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hématolgie- Hôpital privé Cesson-Sévigné</name>
      <address>
        <city>Cesson-Sévigné</city>
        <zip>35510</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne-Violaine DONCKER, MD</last_name>
    </contact>
    <investigator>
      <last_name>Anne-Violaine DONCKER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH William Morey, Service d'Hémato-Oncologie</name>
      <address>
        <city>Chalon-sur-Saône</city>
        <zip>71321</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent VOILLAT, MD</last_name>
    </contact>
    <investigator>
      <last_name>Laurent VOILLAT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Chartres</name>
      <address>
        <city>Chartres</city>
        <zip>28018</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel MAIGRE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Michel MAIGRE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Département d'Oncogénitique - Centre Jean Perrin</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63011</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yves -Jean BIGNON, MD</last_name>
    </contact>
    <investigator>
      <last_name>Yves -Jean BIGNON, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Sud Francilien</name>
      <address>
        <city>Corbeil-Essonnes</city>
        <zip>91100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bertand JOLY, MD</last_name>
    </contact>
    <investigator>
      <last_name>Bertand JOLY, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service d'Hématologie Clinique, CHU de Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denis CAILLOT, MD</last_name>
    </contact>
    <investigator>
      <last_name>Denis CAILLOT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Dunkerque</name>
      <address>
        <city>Dunkerque</city>
        <zip>59 385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie BEAUMONT, MD</last_name>
    </contact>
    <investigator>
      <last_name>Marie BEAUMONT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Médecine Interne-Hématologie, CHU de Fort de France Fort de France</name>
      <address>
        <city>Fort-de-France</city>
        <zip>97200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Côme MENIANE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jean-Côme MENIANE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>GHM, Institut Daniel Hollard</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cécile LEYRONNAS, MD</last_name>
    </contact>
    <investigator>
      <last_name>Cécile LEYRONNAS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Albert Michallon</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brigitte PÉGOURIÉ-BANDELIER, MD</last_name>
    </contact>
    <investigator>
      <last_name>Brigitte PÉGOURIÉ-BANDELIER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service d'Hématologie, CHU de Versailles</name>
      <address>
        <city>Le Chesnay</city>
        <zip>78150</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie RIGAUDEAU, MD</last_name>
    </contact>
    <investigator>
      <last_name>Sophie RIGAUDEAU, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Jean Bernard Clinique Victor Hugo</name>
      <address>
        <city>Le Mans</city>
        <zip>72000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric VOOG, MD</last_name>
    </contact>
    <investigator>
      <last_name>Eric VOOG, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service d'Onco-hématologie, Hôpital Saint-Vincent GH-ICL</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manuel CLIQUENNOIS, MD</last_name>
    </contact>
    <investigator>
      <last_name>Manuel CLIQUENNOIS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service des Maladies du Sang CHU Lille</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry Facon, MD</last_name>
    </contact>
    <investigator>
      <last_name>Thierry Facon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Département d'Oncogénétique, Centre Paoli Calmettes</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hagay Sobol, MD</last_name>
    </contact>
    <investigator>
      <last_name>Hagay Sobol, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laeteitia Huiart, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU d'Annecy</name>
      <address>
        <city>Metz-Tessy</city>
        <zip>74374</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascale CONY- MAKHOUL, MD</last_name>
    </contact>
    <investigator>
      <last_name>Pascale CONY- MAKHOUL, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHR-Metz-Thionville, Hôpital de Mercy, Service d'Hématologie</name>
      <address>
        <city>Metz</city>
        <zip>57085</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Véronique DORVAUX, MD</last_name>
    </contact>
    <investigator>
      <last_name>Véronique DORVAUX, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint-Eloi, Département d'Hématologie clinique</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laure Vincent, MD</last_name>
    </contact>
    <investigator>
      <last_name>Laure Vincent, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service d'Oncologie Médical, Centre Azuréen de Canrérologie-1</name>
      <address>
        <city>Mougins</city>
        <zip>06250</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hervé NAMAN, MD</last_name>
    </contact>
    <investigator>
      <last_name>Hervé NAMAN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU-HÔTEL -Dieu de Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe MOREAU, MD</last_name>
    </contact>
    <investigator>
      <last_name>Philippe MOREAU, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital de l'Archet 1</name>
      <address>
        <city>Nice</city>
        <zip>06202</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Gabriel FUZIBET, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jean-Gabriel FUZIBET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Carémeau</name>
      <address>
        <city>Nîmes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pascal BOURQUARD, MD</last_name>
    </contact>
    <investigator>
      <last_name>Pascal BOURQUARD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut Curie</name>
      <address>
        <city>Paris</city>
        <zip>75248</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claire MATHIOT, MD</last_name>
    </contact>
    <investigator>
      <last_name>Claire MATHIOT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital St Antoine Service des maladies du Sang</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent GARDERET, MD</last_name>
    </contact>
    <investigator>
      <last_name>Laurent GARDERET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jean Paul FermandService Immuno-Hématologie Hôpital Saint Louis</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Paul Fermand, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jean Paul Fermand, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospices Civils de Lyon</name>
      <address>
        <city>Pierre Benite</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles DUMONTET, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Delphine DEMANGEL</last_name>
      <email>delphine.demangel@univ-lyon1.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Charles DUMONTET</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service d'Oncologie-Radiothérapie - CHU Pointe-à-Pitre/Abymes Guadeloupe</name>
      <address>
        <city>POINTE-à-PITRE</city>
        <zip>97159</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Philippe HELIAS, MD</last_name>
    </contact>
    <investigator>
      <last_name>Philippe HELIAS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle AZAIS, MD</last_name>
    </contact>
    <investigator>
      <last_name>Isabelle AZAIS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Robert Debré Service du Professeur A. DELMER Hématologie Clinique</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brigitte KOLB- BIGORGNE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Brigitte KOLB- BIGORGNE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Rennes Hôpital Sud</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier DECAUX, MD</last_name>
    </contact>
    <investigator>
      <last_name>Olivier DECAUX, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Rodez</name>
      <address>
        <city>Rodez</city>
        <zip>12027</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent MOSSER, MD</last_name>
    </contact>
    <investigator>
      <last_name>Laurent MOSSER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital de Saint- Germain en Laye</name>
      <address>
        <city>Saint-Germain-en-Laye</city>
        <zip>78100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole FRENKIEL, MD</last_name>
    </contact>
    <investigator>
      <last_name>Nicole FRENKIEL, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Département d'Hématologie à l'Institut de Cancérologie de la Loire</name>
      <address>
        <city>Saint-Priest-en-Jarez</city>
        <zip>42270</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fressia HONEYMAN, MD</last_name>
    </contact>
    <investigator>
      <last_name>Fressia HONEYMAN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Purpan Service d'Hématologie</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel ATTAL, MD</last_name>
    </contact>
    <investigator>
      <last_name>Michel ATTAL, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Valence</name>
      <address>
        <city>Valence</city>
        <zip>26953</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruno ANGLARET, MD</last_name>
    </contact>
    <investigator>
      <last_name>Bruno ANGLARET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Nancy, Hôpital de Brabois</name>
      <address>
        <city>Vandœuvre-lès-Nancy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aurore Perrot, MD</last_name>
    </contact>
    <investigator>
      <last_name>Aurore Perrot, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 13, 2016</study_first_submitted>
  <study_first_submitted_qc>July 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 2, 2016</study_first_posted>
  <last_update_submitted>February 28, 2018</last_update_submitted>
  <last_update_submitted_qc>February 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dysglobulinemia</keyword>
  <keyword>Multiple Myeloma</keyword>
  <keyword>MGUS</keyword>
  <keyword>Waldenström</keyword>
  <keyword>genetic factors</keyword>
  <keyword>Sequencing</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

